Sanara MedTech Files 8-K on Financial Results
Ticker: SMTI · Form: 8-K · Filed: Mar 24, 2026 · CIK: 0000714256
| Field | Detail |
|---|---|
| Company | Sanara Medtech Inc. (SMTI) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2026 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: earnings, financial-condition, 8-K, results-of-operations
TL;DR
**Sanara MedTech just dropped an 8-K on financial results; check the numbers!**
AI Summary
Sanara MedTech Inc. filed an 8-K on March 24, 2026, reporting under Item 2.02, "Results of Operations and Financial Condition." This indicates the company is likely releasing its latest financial performance, which could include revenue, profit, or loss figures. Investors should pay close attention to the accompanying EX-99.1 exhibit, as it will contain the detailed financial results that will directly impact the stock's valuation and future prospects.
Why It Matters
This filing signals the release of Sanara MedTech's latest financial performance, which is crucial for investors to assess the company's health and future growth potential.
Risk Assessment
Risk Level: medium — The risk is medium because the actual financial results are not yet detailed in this summary, and they could be positive or negative, significantly impacting the stock.
Analyst Insight
A smart investor would immediately locate and review the EX-99.1 exhibit mentioned in the filing to understand the detailed financial results and their implications for Sanara MedTech Inc.'s stock.
Key Players & Entities
- Sanara MedTech Inc. (company) — the filer of the 8-K
- 0000714256 (company) — Sanara MedTech Inc.'s CIK
- 592220004 (company) — Sanara MedTech Inc.'s EIN
FAQ
What specific items were reported in this 8-K filing by Sanara MedTech Inc.?
Sanara MedTech Inc. reported under Item 2.02: Results of Operations and Financial Condition and Item 9.01: Financial Statements and Exhibits, according to the filing details on March 24, 2026.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on March 24, 2026, at 07:10:13.
Filing Stats: 525 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2026-03-24 07:10:13
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SMTI The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 426KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-26-012266.txt ( ) — 668KB
- smti-20260324.xsd (EX-101.SCH) — 3KB
- smti-20260324_lab.xml (EX-101.LAB) — 33KB
- smti-20260324_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 24, 2026 Sanara MedTech Inc . By: /s/ Elizabeth B. Taylor Name: Elizabeth B. Taylor Title: Chief Financial Officer